Switzerland Life Science Jobs for International Candidates

An Interesting Trend We're Seeing Among Chinese Biotech Companies Going Global Over the past few years, one of the most common questions from Chinese biotech companies has been: "How do we get our first global IND approved?" As a result, the market has been actively searching for: • FDA regulatory experts • Clinical pharmacology specialists • Translational scientists • Various functional consultants However, in recent conversations with biotech founders, BD leaders, and development teams, I've noticed the focus beginning to shift. More and more companies are looking for individuals with real global development experience — often under titles such as Global Development Lead, Program Lead, or Development Director. These roles typically require: ✔ Experience in US, Australian, or European clinical development programs ✔ Hands-on involvement in MRCTs (Multi-Regional Clinical Trials) ✔ Strong cross-functional leadership skills ✔ The ability to coordinate clinical, medical, biostatistics, CMC, regulatory, pharmacology, and external CRO teams At first glance, many people assume this is simply a project management role. In reality, companies are searching for something much more valuable: Someone who can think and operate from the Sponsor's perspective. Because Chinese biotech globalization is entering a new phase. The challenge is no longer: "How do we start global development?" The challenge is: "How do we successfully complete global development?" From translational research through registration, critical decisions need to be made continuously around: • Translational strategy • Biomarker strategy and patient selection • Dose selection and clinical pharmacology • Early clinical development in Australia • Global development planning and MRCT execution • Investigator and KOL engagement • CRO and vendor oversight • Regulatory interactions • Portfolio prioritization and milestone decisions • Cross-regional team alignment and risk management In our experience, the success or failure of a development program rarely depends on a single experiment or study outcome. More often, it depends on whether these decisions are connected through a coherent and executable development strategy. This is why I increasingly believe that the future competitive advantage for biotech companies will not be determined solely by scientific innovation. It will also depend on: 🔹 Development efficiency 🔹 Decision quality 🔹 Global execution capability Many emerging biotech companies do not lack individual experts. What they often lack is someone who can connect strategy, science, clinical development, regulatory expectations, and execution into a single development pathway. The next stage of biotech globalization is not just about outsourcing activities. #Biotech #DrugDevelopment #GlobalDevelopment #MRCT #ClinicalDevelopment #TranslationalMedicine #MIDD #DrugDevelopmentStrategy #BiotechLeadership #GlobalBiotech

Did you know Canada’s pharmaceutical sector is a global powerhouse, ranking 9th in the world and representing 2% of global sales? However, the most critical statistic behind this growth is the workforce: Canada now supports more than 80,000 high-skilled jobs. For talent acquisition teams and hiring leaders, this reality brings unique challenges: - The annual 2 billion dollar R&D spend means relentless demand for top-tier scientists and clinical operations specialists who want to work on cutting-edge therapies. - The definition of pharma talent has expanded. We are increasingly looking at the intersection of life sciences, bioinformatics, and data analytics. - In a top-10 global market, high-skilled candidates have choices. If you are looking to build or scale in this competitive industry, let's connect! #LifeSciences #Pharmaceuticals #Recruitment #TalentAcquisition #CanadaJobs

Theoretical knowledge gets you to the interview. Practical judgment gets you the job. We have created a Clinical Research Associate Practical Interview Preparation Guide covering 20 real world scenario based questions from entry level to senior level, with detailed answers and explanations grounded in GCP, ICH E6, and actual clinical trial operations. This guide covers scenarios including informed consent violations, investigational product discrepancies, serious adverse event reporting failures, source data verification findings, protocol deviations, subject eligibility violations, delegation log compliance, inspection readiness, temperature excursions, data integrity issues, and multi-site prioritization decisions. If you are preparing for a CRA role at any level, this is the resource that prepares you for what interviewers actually ask when they want to know how you think, decide, and act on the ground. 🔗 Register: https://lnkd.in/dpc6kv_G for access 📩 Mail: support@ccrest.in for faster access (After Registration only) #ClinicalResearchAssociate #CRAInterview #ClinicalResearch #ClinicalTrials #GoodClinicalPractice #GCP #ICHE6 #ClinicalMonitoring #SiteMonitoring #SourceDataVerification #SDV #ProtocolDeviation #CAPA #AdverseEvent #SeriousAdverseEvent #InformedConsent #InvestigationalProduct #TrialMasterFile #TMF #RiskBasedMonitoring #ClinicalOperations #ClinicalResearchJobs #CRACareers #PharmaCareers #LifeSciences #Biotechnology #PharmaceuticalIndustry #DrugDevelopment #ClinicalResearchTraining #InterviewPreparation #InterviewTips #CareerDevelopment #ProfessionalDevelopment #BPharm #MPharm #PharmD #ClinicalResearchIndia #PharmaIndia #HealthcareCareers #DataIntegrity #InspectionReadiness #DelegationLog #TemperatureExcursion #ClinicalCompliance #RegulatoryCompliance #CRO #CCREST #IQVIA #Covance #LabcorpDrugDevelopment #PPD #Syneos #SyneosHealth #PRA #PRAHealthSciences #Parexel #CharlesRiver #CharlesRiverLaboratories #Medpace #Fortrea #Novatek #TigermedCRO #Tigermed #CliniSys #Veeva #Medidata #OracleClinical #IconPlc #ICON #Worldwide #WorldwideClinicalTrials #Ergomed #Clinipace #PsychogenicsInc #Celerion #Theorem #INCResearch #Chiltern #Quintiles #QIAGEN #Lonza #Wuxi #WuXiAppTec #KentuckyBioProcessing #EastClinical #Navitas #NavitasLifeSciences #Quotient #ArisGlobal #DataRevival #Premier #PremierResearch #Criterium #Pacific #PacificBioLabs #Corcept #CoreLab #BioClinica #Clario #Medidata #Rave #OracleInForm #VeevaVault

Japan Life Sciences Market Pulse June 2026 As we enter the second half of 2026, here are three observations from Japan’s life sciences market. 1. Funding is gradually returning While investment remains selective, companies with strong clinical or commercial milestones continue to secure capital. Insight: Funding doesn’t create hiring overnight, but it often signals increased recruitment within the following 3–12 months. ⸻ 2. Business Development (Licensing) is becoming a critical hiring priority As more Japanese biotech companies pursue out-licensing opportunities with U.S. and global pharmaceutical companies, demand for Business Development (Licensing) professionals continues to grow. In our view, this is one of the most difficult functions to hire in Japan’s life sciences sector. Key reasons include: * The need for both scientific expertise and commercial acumen. * Limited professionals with cross-border partnering experience. * Strong English communication and negotiation skills are essential. * A highly competitive talent pool. Insight: Successful partnering starts long before a deal is signed—it begins with hiring the right people. ⸻ 3. Specialist hiring remains challenging Demand continues to outpace supply for highly specialized talent, particularly in: * CMC * Manufacturing * Regulatory Affairs * Quality Assurance * Clinical Operations * Business Development (Licensing) Companies may be hiring more selectively, but they continue to invest in roles that directly influence development, regulatory execution and long-term growth. ⸻ Our Perspective From our conversations across the industry, the market is becoming more selective—not inactive. Organizations that continue to hire successfully tend to: * Move quickly through the hiring process. * Clearly define candidate profiles. * Build talent pipelines before hiring becomes urgent. * Invest early in Business Development capabilities to support future partnering activities. Starting this month, we will publish the Japan Life Sciences Market Pulse at the beginning of each month, sharing observations on hiring trends, funding activity, business development, licensing and other developments shaping Japan’s life sciences ecosystem. We hope this becomes a useful resource for professionals, founders, investors and companies operating in the sector. Sources * GForce Life Sciences – Mid-Year Biotech Hiring Forecast https://lnkd.in/ggWe2DMB * Trading Economics – Japan Jobs-to-Applicants Ratio https://lnkd.in/g9yCQXRN #LifeSciences #Biotech #MedTech #BusinessDevelopment #Licensing #CMC #RegulatoryAffairs #ClinicalOperations #Japan #ExeraBioPartners

Australia’s biotechnology sector has extraordinary potential, but achieving sustainable growth will depend on one critical factor: building a workforce with the right skills, experience, and capability. After many years of discussions with industry leaders, employers, educators, and regulatory professionals, I believe the time for conversation alone has passed. It is time for action. We must work together, industry, academia, training providers, and government to develop the talent pipeline that will underpin the future success of Australia’s biotechnology and life sciences sectors. I am proud to stand alongside the industry organisations and companies that are taking this challenge seriously and investing in practical solutions to strengthen workforce capability. I look forward to participating in the 2026 SeerPharma Symposium in Sydney this morning, where we will explore the ongoing and future demand for GMP expertise and the importance of industry-focused GMP qualifications. I’ll also be sharing my perspectives on workforce capability development, current recruitment trends, and why practical GMP training is becoming an increasingly important consideration when hiring graduates, including those who have completed the SeerPharma flagship GMP program. Developing Australia’s future biotechnology workforce is not simply about filling vacancies; it’s about creating the capability that will enable innovation, manufacturing excellence, and global competitiveness for decades to come. If you’re attending the symposium, I look forward to connecting. If not, and you’d like to continue the conversation around workforce planning, capability development, or recruitment strategies for the biotechnology sector, please reach out. The future of our industry depends on the workforce that we access, build and support. University of Technology Sydney KE Select - Scientific & Medical Recruitment Specialists #gmpmanufacturing #workforceplanning #accesstalent

The Most In-Demand Pharma Professions: Russia vs. Western countries While looking for a job, I became interested in pharma trends. In global reports such as Pharma Career Outlook, In-Demand Pharma Roles, and Pharma Jobs 2026 Demand Roles and Hiring Trends, the same roles come up again and again: regulatory affairs, pharmacovigilance, CRA, clinical data science, and advanced manufacturing. That makes sense: the global market increasingly values professionals who can connect clinical expertise, data, and regulation. What about Russia? According to Medargo, over the past few years demand for quality engineers has grown by 66%, for technologists by 21%, and for blue-collar workers by 34%. Industry estimates also suggest that demand for staff may have increased by another 25–30% by 2025–2026. If we look at office-based roles, the biggest shortages are in sales, commercial functions, marketing, and IT. Conclusion: The global and Russian markets are moving in the same direction, but they are at different stages: abroad, companies are looking for multidisciplinary expertise, while in Russia the priority is still closing the basic staffing gap. #Pharma #PharmaTrends #PharmaJobs #Healthcare #LifeSciences #RegulatoryAffairs #Pharmacovigilance #ClinicalResearch #ClinicalDataScience #CRA #Manufacturing #QualityAssurance #TalentAcquisition #Recruitment #HiringTrends #Russia #GlobalMarket #JobSearch

Irish Life Sciences | H1 2026 Market Review The first half of 2026 has shown that Ireland remains one of the world's leading life sciences locations, with investment, talent and innovation continuing to drive the sector. 📈 IDA Ireland announced commitments for 10,400 new multinational jobs in H1 2026, slightly ahead of H1 2025. While this spans all sectors, life sciences continues to be one of the country's strongest drivers of inward investment and high-value manufacturing. 🏭 Ireland continued to strengthen its position in biologics, advanced manufacturing and next-generation therapies, while the Government progressed its first #NationalLifeSciencesStrategy, designed to accelerate R&D, innovation and long-term competitiveness. 🤖 Digital transformation, AI, automation and advanced manufacturing remain key investment priorities, driving demand for professionals with experience in GMP, validation, CQV, process engineering, quality, data analytics and regulatory science. 👥 Recruitment Market Insight 🔹 The market has become more selective rather than slower. Companies are still hiring, but interview processes are taking longer than expected. 🔹 Specialist talent remains highly competitive. Validation Engineers, CQV Engineers, Quality professionals, Automation Engineers and experienced Manufacturing leaders continue to receive multiple approaches and are often progressing through 2-4 interview processes simultaneously. 🔹 #Contract hiring has remained resilient, with many organisations using contractors to deliver expansion projects while taking a more measured approach to permanent headcount growth. 🔹 Candidates are placing greater emphasis on career progression, project pipeline, flexibility and company stability, not just salary. For employers, speed continues to be a competitive advantage, as top candidates rarely remain available for long. 📅 June Highlights 🚀 The National Life Sciences Strategy moved closer to publication, signalling a major long-term commitment to strengthening Ireland's position as a global life sciences hub. 🏆 Industry leaders gathered to celebrate innovation, manufacturing excellence and operational achievements at Ireland's annual Life Sciences awards. 📊 Overall, H1 2026 can be described as a market of steady investment, cautious hiring, continued skills shortages and strong demand for experienced technical talent particularly across GMP manufacturing, engineering, quality, validation and advanced therapies. ACCPRO Beth Kenny Dave O'Flaherty #LifeSciences

India's First Online Free Pharma Symposium: Career Launchpad & Hidden Careers in Pharma 🚀💊 🔗 https://lnkd.in/dixuuZ92 The pharmaceutical industry is evolving faster than ever, creating opportunities far beyond traditional roles in manufacturing, quality control, and sales. Yet, many pharmacy students and professionals remain unaware of the vast career avenues available to them. To bridge this gap, we are excited to announce India's First Online Free Pharma Symposium – Career Launchpad & Hidden Careers in Pharma! This unique initiative is designed to help students, fresh graduates, and working professionals discover emerging and high-growth career paths within the pharmaceutical and healthcare ecosystem. 🎯 What You Will Learn: ✅ Hidden career opportunities in Pharma ✅ Medical Affairs & Medical Science Liaison (MSL) ✅ Pharmacovigilance (PV) ✅ Clinical Research & Clinical Data Management (CDM) ✅ Regulatory Affairs ✅ Market Research & Competitive Intelligence ✅ Healthcare Analytics & AI in Pharma ✅ Higher Education & Global Career Pathways ✅ Industry expectations and skill-building strategies 👨⚕️👩⚕️ Who Should Attend? D.Pharm, B.Pharm, M.Pharm, Pharm.D students Fresh graduates seeking career direction Working professionals planning a career transition Aspirants preparing for industry opportunities This symposium aims to provide practical insights, expert guidance, and a clear roadmap for building a successful pharmaceutical career. Whether your goal is to enter the industry, switch domains, or explore emerging opportunities, this event will help you make informed career decisions. 🌟 Key Highlight: Completely FREE and accessible from anywhere in India. The future of pharma belongs to professionals who understand opportunities beyond the conventional path. Join us and discover where your pharmacy degree can truly take you. 📌 Your career breakthrough could be one session away. #PharmaSymposium #PharmacyCareer #CareerLaunchpad #HiddenCareersInPharma #BPharm #MPharm #PharmD #PharmaStudents #PharmaceuticalIndustry #MedicalAffairs #MSL #Pharmacovigilance #ClinicalResearch #ClinicalDataManagement #RegulatoryAffairs #HealthcareAnalytics #PharmaJobs #PharmaProfessionals #CareerGuidance #FutureOfPharma

Japan Life Sciences Hiring Trends – July 2026 Hiring activity remained resilient in July despite a generally cautious market environment. Biotech hiring continues at a healthy pace, while R&D recruitment remains selective with limited new openings. Demand for Clinical Development talent remains strong, particularly for CRA and Pharmacovigilance roles across both pharmaceutical companies and CROs. Manufacturing hiring continues to be robust, with increasing demand for experienced mid-level and leadership talent, especially in the Kansai region. Medical Affairs hiring remains active, particularly for MSLs, while Commercial and specialty Sales roles—including immunology and rare diseases—continue to offer attractive opportunities. Feel free to reach out if you are hiring or exploring opportunities in Japan. #Japan #Pharma #Biotech

𝟕 𝐫𝐞𝐬𝐨𝐮𝐫𝐜𝐞𝐬 𝐞𝐯𝐞𝐫𝐲 𝐏𝐡𝐚𝐫𝐦𝐚cy 𝐬𝐭𝐮𝐝𝐞𝐧𝐭 𝐬𝐡𝐨𝐮𝐥𝐝 𝐛𝐨𝐨𝐤𝐦𝐚𝐫𝐤 𝐫𝐢𝐠𝐡𝐭 𝐧𝐨𝐰.:- Most of us rely on textbooks and class notes. But the students who stand out are the ones who know where to find real, updated, credible information. Here's what I actually use: 𝟏. 𝐏𝐮𝐛𝐌𝐞𝐝 — The gold standard for medical and pharmaceutical research. Every drug study, clinical trial, and review paper lives here. Start using it before your final year, it changes how you read and think. Link - https://lnkd.in/dCag_J2f 𝟐. 𝐃𝐫𝐮𝐠𝐬.𝐜𝐨𝐦 — My go-to for quick drug monographs, interactions, dosage, and side effect profiles. Clear, structured, and updated regularly. Perfect for internships and case studies. Link - https://www.drugs.com/ 𝟑. 𝐖𝐇𝐎 𝐄𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐋𝐢𝐬𝐭 — Understand which drugs matter globally and why. Gives you a macro view of pharmaceutical policy that textbooks rarely cover. Link - https://lnkd.in/dZ_hkHGJ 𝟒. 𝐏𝐡𝐚𝐫𝐦𝐆𝐊𝐁 — Pharmacogenomics database - how genetics affects drug response. If you want to understand personalized medicine, this is where you start. Link - pharmgkb.org 𝟓. 𝐃𝐫𝐮𝐠𝐁𝐚𝐧𝐤 — Incredibly detailed drug data — mechanisms, targets, pathways, interactions. Brilliant for pharmacology assignments and research. Link - https://go.drugbank.com/ 𝟔. 𝐈𝐧𝐝𝐢𝐚𝐧 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐩𝐨𝐞𝐢𝐚 — Non-negotiable for Indian pharmacy students. Standards, monographs, and quality specifications for drugs in India. Know this well. Link - https://lnkd.in/drEjEYvS 𝟕. 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥𝐓𝐫𝐢𝐚𝐥𝐬.𝐠𝐨𝐯 — See real, ongoing trials for drugs you're studying. Connects classroom theory directly to real-world pharmaceutical development. Link - https://lnkd.in/dG-w5QGP These aren't just student tools. PubMed, Drug Bank, and ClinicalTrials.gov are used daily by researchers, medical writers, regulatory professionals, and clinical pharmacists worldwide. The earlier you get comfortable with them, the more confident you'll be in every internship, viva, and job interview. #pharmacy #Drugs #Clinicaltrial #Research #Medicine